Presentation Slides
Back to course
Pdf Summary
Clozapine Risk Evaluation and Mitigation Strategy
REMS program changes
prescriber guidance
pharmacist guidance
Clinical Support System for Serious Mental Illness
severe neutropenia management
Benign Ethnic Neutropenia
ANC monitoring recommendations
prescriber re-certification
REMS Dispense Authorization
Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.
Powered By